Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs

Cardiovasc Res. 2011 Mar 1;89(4):843-51. doi: 10.1093/cvr/cvq359. Epub 2010 Nov 13.

Abstract

Aims: The goal was to terminate atrial fibrillation (AF) by targeting atrioventricular differences in ionic properties.

Methods and results: Optical mapping was used to record electrical activity during carbachol (0.25-0.5 μM)-induced AF in pig hearts. The atrial-specific current, I(Kur), was blocked with 100 μM 4-aminopyridine (4-AP) or with 0.5 μM DPO-1. Hearts in AF and ventricular fibrillation (VF) were also subjected to increasing levels of extracellular K(+) ([K(+)](o): 6-12 mM), compared with controls (4 mM). We hypothesized that due to the more negative steady-state half inactivation voltage for the atrial Na(+) current, I(Na), compared with the ventricle, AF would terminate before VF in hyperkalaemia. Mathematical models were used to interpret experimental findings. The I(Kur) block did not terminate AF in a majority of experiments (6/9 with 4-AP and 3/4 with DPO-1). AF terminated in mild hyperkalaemia ([K(+)](o) ≤ 10.0 mM; N = 8). In contrast, only two of five VF episodes terminated at the maximum ([K(+)](o): 12 mM [K(+)](o)). The I(Kur) block did not terminate a simulated rotor in cholinergic AF because its contribution to repolarization was dwarfed by the large magnitude of the acetylcholine-activated K(+) current (I(K,ACh)). Simulations showed that the lower availability of the atrial Na(+) current at depolarized potentials, and a smaller atrial tissue size compared with the ventricle, could partly explain the earlier termination of AF compared with VF during hyperkalaemia.

Conclusion: I(Kur) is an ineffective anti-arrhythmic drug target in cholinergic AF. Manipulating Na(+) current 'availability' might represent a viable anti-arrhythmic strategy in AF.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Action Potentials / drug effects
  • Animals
  • Atrial Fibrillation / drug therapy*
  • Computer Simulation
  • Hyperkalemia / physiopathology
  • Male
  • Phosphines / pharmacology
  • Potassium / metabolism
  • Potassium Channel Blockers / therapeutic use*
  • Swine

Substances

  • (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide
  • Phosphines
  • Potassium Channel Blockers
  • 4-Aminopyridine
  • Potassium